$1.42
2.07% yesterday
Nasdaq, Aug 11, 10:00 pm CET
ISIN
US98986M1036
Symbol
ZYXI

Zynex, Inc. Stock price

$1.42
-0.82 36.61% 1M
-6.06 81.02% 6M
-6.59 82.27% YTD
-5.96 80.76% 1Y
-8.41 85.55% 3Y
-14.74 91.21% 5Y
+1.28 912.84% 10Y
+0.90 173.08% 20Y
Nasdaq, Closing price Mon, Aug 11 2025
-0.03 2.07%

Key metrics

Basic
Market capitalization
$78.0m
Enterprise Value
$120.6m
Net debt
$42.5m
Cash
$17.5m
Shares outstanding
30.8m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
0.5 | 0.7
EV/Sales
0.8 | 1.0
EV/FCF
negative
P/B
61.9
Dividends
DPS
$0.00
Yield 1Y | 5Y
0.0% | 0.0%
Growth 1Y | 5Y
- | -
Payout 1Y | 3Y
0.0% | 11.4%
Increased
0 Years
Financials (TTM | estimate)
Revenue
$144.8m | $118.9m
EBITDA
$-15.5m | $-11.8m
EBIT
$-20.1m | $-28.7m
Net Income
$-28.7m | $-24.6m
Free Cash Flow
$-7.7m
Growth (TTM | estimate)
Revenue
-25.2% | -38.2%
EBITDA
-244.9% | -290.6%
EBIT
-291.1% | -579.7%
Net Income
-575.3% | -921.7%
Free Cash Flow
-144.7%
Margin (TTM | estimate)
Gross
75.6%
EBITDA
-10.7% | -10.0%
EBIT
-13.9%
Net
-19.8% | -20.7%
Free Cash Flow
-5.3%
Financial Health
Equity Ratio
29.3%
Return on Equity
8.4%
ROCE
-166.7%
ROIC
-
Debt/Equity
47.7
More
EPS
$-0.9
FCF per Share
$-0.2
Short interest
22.3%
Employees
1k
Rev per Employee
$190.0k
Show more

Is Zynex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Zynex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Zynex, Inc. forecast:

6x Buy
67%
3x Hold
33%

Analyst Opinions

9 Analysts have issued a Zynex, Inc. forecast:

Buy
67%
Hold
33%

Financial data from Zynex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
145 145
25% 25%
100%
- Direct Costs 35 35
7% 7%
24%
110 110
30% 30%
76%
- Selling and Administrative Expenses 130 130
11% 11%
89%
- Research and Development Expense - -
-
-
-15 -15
245% 245%
-11%
- Depreciation and Amortization 4.65 4.65
2,806% 2,806%
3%
EBIT (Operating Income) EBIT -20 -20
291% 291%
-14%
Net Profit -29 -29
575% 575%
-20%

In millions USD.

Don't miss a Thing! We will send you all news about Zynex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Zynex, Inc. Stock News

Neutral
The Motley Fool
6 days ago
Zynex Q2 Revenue Drops 55%
Neutral
Seeking Alpha
11 days ago
Zynex, Inc. (NASDAQ:ZYXI ) Q2 2025 Earnings Conference Call July 31, 2025 4:15 PM ET Company Participants Anna Lucsok - Chief Operating Officer Daniel J. Moorhead - Chief Financial Officer Donald Gregg - President of Zynex Monitoring Solutions Thomas Sandgaard - Founder, President, CEO & Chairman Conference Call Participants Jeffrey Scott Cohen - Ladenburg Thalmann & Co. Inc., Research Division...
Positive
Proactive Investors
11 days ago
Zynex Inc (NASDAQ:ZYXI), a developer of non-invasive medical devices, is laying the foundation for a return to growth following a pivotal second quarter marked by leadership changes, operational streamlining, and a key FDA submission for its next-generation pulse oximeter. The company appointed industry veteran Steven Dyson as CEO in Q2, a move founder Thomas Sandgaard called “transformational”...
More Zynex, Inc. News

Company Profile

Zynex, Inc. engages in the design, manufacture, and marketing of medical devices. It sells electrotherapy medical devices used for pain management and rehabilitation. The company also develops a new blood volume monitor for use in hospitals and surgery centers. Zynex was founded by Thomas Sandgaard in 1996 and is headquartered in Englewood, CO.

Head office United States
CEO Thomas Sandgaard
Employees 1,000
Founded 1996
Website www.zynex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today